Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Ophthalmol Retina. 2020 Feb 11;4(7):720–727. doi: 10.1016/j.oret.2020.02.001

Table 1.

Baseline clinical information.

Patient Gender GA at Birth (weeks) BW (g) Previous treatment for ROP in the affected eye Age at presentation (years) Visual acuity at presentation Clinical features at time of onset
Affected eye Fellow eye
1 Male 23 624 Laser, vitrectomy, scleral buckle, lensectomy 17 20/200 NLP Vitreous hemorrhage, subretinal yellow exudation, pigmentary disturbance in posterior pole OD
2 Male 25 680 Laser, scleral buckle 19 20/250 NLP Superior dry fold, subretinal yellow exudation, pigmentary disturbance in posterior pole OD
3 Female 26 Unknown None 43 20/200 20/250 Subhyaloid hemorrhage, subretinal yellow exudation, pigmentary disturbance in posterior pole OS
4 Female 28 1106 Laser, vitrectomy, scleral buckle, lensectomy 13 20/200 20/200 Subretinal yellow exudation, fibrovascular proliferation with optic disc dragging, pigmentary disturbance in posterior pole OD
5 Female 27 853 None 41 20/40 NLP Subretinal yellow exudation, reactive retinal astrocytic tumor, pigmentary disturbance in posterior pole OS

GA- Gestational Age, BW - Birthweight, NLP - No light perception, PMA - Post-menstrual age.